Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Naltrexone × Other × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Obesity 3 Overweight 2 Breast Neoplasms 2 Metabolic Syndrome 1 Inflammation 1 Dyslipidemias 1

Interventions

semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Topiramate 1 Tirzepatide 1 Tablets 1 Specimen Handling 1 Qsymia 1 Pregabalin 1 Phentermine 1 Omeprazole 1 Nutrition Assessment 1 Naltrexone 1 Liraglutide 1 Ketorolac 1 Glucagon-Like Peptide-1 Receptor 1 Exercise 1 Diethylpropion 1 Diet 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡